Dr. Khwaja Abdul Hamied’ born on 31 October 1898 in Alighar to Khwaja Abdul Ali and Masood Jahan Begum was an Indian nationalist and anti-imperialist scientist who founded Cilla, India's oldest pharmaceutical company in 1935. His son, Yusuf Hamied headed the company after him for the next 52 years.

Early life and background

Hamied was born in Aligarh, Uttar Pradesh, and later graduated from Allahabad University in Allahabad, Uttar Pradesh and held M.A. and PhD degrees from the Humboldt University of Berlin in Germany. He was a disciple of M.K. Gandhi and former founder professor along with Zakir Husain of the Jamia Milia Islamia in Aligarh, now based in Delhi.

Career

Hamied followed Mahatma Gandhi's Indian nationalism. Hamied's family raised money to send him to study chemistry in England, India's colonial master, in 1924. Instead, he changed ships and went to Germany, then the world's leader in chemicals. On a Berlin lake, he met a Lithuanian Jewish socialist, whom he married. They fled as the Nazis rose to power in Germany.

Chemical, Industrial and Pharmaceutical Laboratories (CIPLA) was founded in 1935 with an initial capital of Rs. 2 lakhs. The company commenced production in 1937 making it the oldest pharmaceutical company in India. His eldest son Yusuf Hamied, who did study chemistry in England, is now Chairman of Cipla. Yusuf still refers to his chemistry notebooks from Cambridge.
Apart from conceiving the idea of establishing a National Chemical Laboratory and making it a reality, Dr Khwaja Hamied floated the idea and conceptualized the establishment of the Council of Scientific and Industrial Research (CSIR) as an umbrella organization to run a clutch of laboratories. He remained a Member of the Governing Body of the CSIR right from its inception till the very last 
During the last four decades of his life, he played an important role in raising the pharmaceutical and chemical industry standards in India to an extraordinarily high level through founding the firm Cipla.
Dr. Hamied was an honorary professor and a member of the executive council of the Aligarh Muslim University, member of the Senate of Bombay University and a fellow of theRoyal Institute of Chemistry, UK. He was also a member of the Bombay Legislative Council from 1937–1962, refusing the offer of becoming a Muslim Minister in the cabinet in Bombay. Hamied also served as Sheriff of Bombay.
Dr Khwaja Abdul Hamied passed away in 1972 after a brief illness.

Yusuf Khwaja Hamied (born 1936) is a leading Indian scientist and chairman of Cipla, a socially conscious generic pharmaceuticalscompany founded by his father Khwaja Abdul Hamied in 1935.
He was awarded the Padma Bhushan, India's third highest civilian honour by Government of India in 2005

Early life and background

Born in Vilnius, Lithuania,on July 25th 1936. Yusuf Hamied was raised in Bombay. His Indian Muslim father and Russophone Jewish mother met in pre-war Berlin, where they both were graduate students. He holds a Ph.D. in chemistry from Christ's College, Cambridge. He still uses his chemistry notebooks from Cambridge when he develops new syntheses of drugs.
He is an alumnus of the Cathedral and John Connon School in Bombay. Affectionately called Yuku by his close friends, Hamied is fond of Western classical music and has been close friends with the world-famous conductor Zubin Mehta since boyhood.

Career

Hamied is best known outside India for defying large Western pharmaceutical companies in order to provide generic AIDS drugs and treatments for other ailments primarily affecting people in poor countries. He was awarded the Padma Bhushan by the Government of India in 2005.
Hamied has led efforts to eradicate AIDS in the developing world and to give patients life-saving medicines regardless of their ability to pay, and has often been characterized as a modern-day Robin Hood figure as a result.
Former head of Johnson and Johnson Ajit Dangi says plainly "In Africa, Cipla is a temple and Dr. Hamied is God." To this Hamied has countered "I don't want to make money off these diseases which cause the whole fabric of society to crumble".
In September 2011, in a piece about how he was trying to radically lower costs of biotech drugs for cancer, diabetes and other noncommunicable diseases, The New York Timeswrote of Hamied:
Dr. Yusuf K. Hamied, chairman of the Indian drug giant Cipla Ltd., electrified the global health community a decade ago when he said he could produce cocktails of AIDS medicines for $1 per day — a fraction of the price charged by branded pharmaceutical companies. That price has since fallen to 20 cents per day, and more than six million people in the developing world now receive treatment, up from little more than 2,000 in 2001.
Yusuf Hamied has also been enormously influential in pioneering development of multi-drug combination pills (also known as fixed-dose combinations, or FDCs), notably forHIV/AIDS, tuberculosis (TB), asthma and other ailments chiefly affecting developing countries, as well as development of pediatric formulations of drugs, especially those benefiting children in poor settings. These innovations have greatly expanded access to medicine and increased drug safety by ensuring proper dosages are taken. He is also highly regarded for his leading role in expanding the production of bulk drugs and "active pharmaceutical ingredients" (APIs, the active chemical components in medicines) in India.
In 2009 the Yusuf Hamied Centre was opened at Christ's College, Cambridge
Yusuf Hamied has been the subject of in-depth profiles in The New York Times, Time magazine, The Guardian, Le Monde, The Economist, the Financial Times, The Times (London), Corriere della Sera, Der Spiegel, Wired and numerous other leading publications, as well as on television outlets such as ABC News, the BBC, CNN and CBS' 60 Minutes.
In February 2013, he announced his retirement plans from Cipla after remaining managing director of the company for last 52 years. [ At the time, he was 28th richest Indian as per Forbes.

It was founded by Dr. Khwaja Abdul Hamied as 'The Chemical, Industrial & Pharmaceutical Laboratories' in 1935 in Mumbai.
The name of the Company was changed to 'Cipla Limited' with effect from 20 July 1984, wherein the word Cipla came from the first letters of each word in the old name 'TheChemical, Industrial & Pharmaceutical Laboratories'.
In the year 1985, US FDA approved the company's bulk drug manufacturing facilities.
In 1994, Cipla launched Deferiprone, the world’s first oral iron chelator.
In 2001, Cipla offered medicines (antiretrovirals) for HIV treatment at a fractional cost (less than $350 per year per patient).
In 2012, the company slashed prices of three life-saving cancer drugs by 50-64%.
In 2013, it increased its stake in its South African joint venture CIPLA Medpro from 50% to 100% stake for INR27 billion (US$420 million) to strengthen its position in the African continent. Cipla Medpro is the third largest South African pharmaceutical company and it was founded in 1993.